000 01462 a2200397 4500
005 20250517234418.0
264 0 _c20181211
008 201812s 0 0 eng d
022 _a1873-4863
024 7 _a10.1016/j.jbiotec.2018.08.015
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSilva, Marta M
245 0 0 _aFull-length human CCBE1 production and purification: leveraging bioprocess development for high quality glycosylation attributes and functionality.
_h[electronic resource]
260 _bJournal of biotechnology
_cNov 2018
300 _a6-14 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAngiogenesis Inducing Agents
_xmetabolism
650 0 4 _aCalcium-Binding Proteins
_xgenetics
650 0 4 _aCell Line
650 0 4 _aGlycosylation
650 0 4 _aHuman Umbilical Vein Endothelial Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aNeovascularization, Physiologic
_xdrug effects
650 0 4 _aRecombinant Proteins
_xmetabolism
650 0 4 _aTumor Suppressor Proteins
_xgenetics
700 1 _aGomes-Alves, Patrícia
700 1 _aRosa, Sara
700 1 _aSimão, Daniel
700 1 _aInácio, José M
700 1 _aPeixoto, Cristina
700 1 _aSerra, Margarida
700 1 _aBelo, José A
700 1 _aAlves, Paula M
773 0 _tJournal of biotechnology
_gvol. 285
_gp. 6-14
856 4 0 _uhttps://doi.org/10.1016/j.jbiotec.2018.08.015
_zAvailable from publisher's website
999 _c28786235
_d28786235